Alexandra Drakaki, MD

Alexandra Drakaki, MD, of University of California, Los Angeles

Articles by Alexandra Drakaki, MD

CtDNA Clearance With Neoadjuvant Durvalumab Plus Tremelimumab and EV for Cisplatin-Ineligible MIBC

Alexandra Drakaki, MDMuscle Invasive Urothelial Carcinoma | September 25, 2024

Dr. Drakaki highlights the VOLGA study and its practice-changing potential for patients with muscle-invasive bladder cancer.